Cargando…
Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation
BACKGROUND: Renal interstitial fibrosis (RIF) is a common pathway to end-stage renal disease regardless of the initial etiology. Currently, the molecular mechanisms for RIF remains not fully elucidated. Nuclear receptor subfamily 4 group A member 1(Nr4a1), a member of the NR4A subfamily of nuclear r...
Autores principales: | Tao, Yilin, Tang, Chengyuan, Wei, Ju, Shan, Yi, Fang, Xi, Li, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169452/ https://www.ncbi.nlm.nih.gov/pubmed/37161357 http://dx.doi.org/10.1186/s10020-023-00657-y |
Ejemplares similares
-
Anp32e promotes renal interstitial fibrosis by upregulating the expression of fibrosis-related proteins
por: Wei, Ju, et al.
Publicado: (2022) -
NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis
por: Tian, Jiao, et al.
Publicado: (2021) -
Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation
por: Zheng, Meiling, et al.
Publicado: (2019) -
p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients
por: Lee, Jeonghwan, et al.
Publicado: (2019) -
Ginaton injection alleviates cisplatin-induced renal interstitial fibrosis in rats via inhibition of apoptosis through regulation of the p38MAPK/TGF-β1 and p38MAPK/HIF-1α pathways
por: Liang, Taolin, et al.
Publicado: (2021)